Skip to main content
logo
Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
151.73
+1.72 (1.15%)
Jun 30, 2025, 4:00 PM - Market closed

CRL Revenue

Charles River Laboratories International had revenue of $984.17M in the quarter ending March 29, 2025, a decrease of -2.71%. This brings the company's revenue in the last twelve months to $4.02B, down -2.16% year-over-year. In the year 2024, Charles River Laboratories International had annual revenue of $4.05B, down -1.92%.

Revenue (ttm)
$4.02B
Revenue Growth
-2.16%
P/S Ratio
1.91
Revenue / Employee
$200,129
Employees
20,100
Market Cap
7.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 28, 20244.05B-79.42M-1.92%
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 20202.92B302.71M11.55%
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 26, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

CRL News

More News